Columbus, OH
Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.
invirsa.comThese are collections Invirsa is a part of. Click on the collection name to view similar companies.
Series B
$7,700,000
Series B
$7,700,000
Series Unknown
$5,976,217
Series Unknown
$5,976,217
Series A
$1,800,000
Series A
$1,800,000
Seed
$520,000
Seed
$520,000
Convertible Note
$149,000
Convertible Note
$149,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Invirsa.